Summary & Overview
CPT 32561: Intrapleural Fibrinolytic Injection via Chest Tube
CPT code 32561 describes the initial-day intrapleural administration of a fibrinolytic agent through a chest tube or catheter to dissolve fibrinous material in the pleural space. The code is clinically important for management of complicated pleural effusions and empyema when enzymatic breakdown of fibrinous loculations is indicated. Nationally, proper coding of this service affects clinical documentation, care coordination in inpatient and hospital outpatient settings, and claims adjudication for a procedure-intensive therapy.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical settings of service, followed by benchmarking and coverage considerations across major payers where available. The publication highlights coding elements tied to first-day treatment recognition and outlines the operational implications for hospital coding teams and billing staff. Data not available in the input is noted where applicable; the content focuses on clarifying what CPT code 32561 represents, why it matters to reimbursement and clinical workflows, and what elements clinicians and coders should expect to see documented for intrapleural fibrinolytic therapy.
Billing Code Overview
CPT code 32561 describes the injection of a chest tube or catheter with a fibrinolytic agent to dissolve fibrinous material within the pleural space. This code captures all related services performed on the first day of treatment.
-
Service type: Therapeutic intrapleural fibrinolytic therapy via chest tube or catheter
-
Typical site of service: Hospital inpatient or hospital outpatient setting where chest tube management and intrapleural medication administration are performed
Clinical & Coding Specifications
Clinical Context
A 68-year-old hospitalized patient with a history of congestive heart failure and pneumonia develops a complicated parapneumonic effusion with loculations and persistent drainage from an indwelling chest tube. Fibrinous septations limit effective drainage and the patient remains febrile with rising inflammatory markers. The thoracic surgery team and pulmonology consult decide to administer intrapleural fibrinolytic therapy through the existing chest tube to dissolve fibrinous adhesions and improve evacuation of the pleural fluid. On the first day of treatment the provider prepares the fibrinolytic agent (for example, tissue plasminogen activator) under sterile technique, injects the agent through the chest tube catheter, documents the time, dose, lot number, and patient response, and monitors drainage and vital signs for several hours. Nursing documents drainage volume and character, and imaging (chest radiograph or ultrasound) may be obtained subsequently to assess lung re-expansion. This workflow encompasses the procedure components described by 32561 for the initial day of intrapleural fibrinolytic administration.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician/professional portion of a service if a separate technical component exists (rare for this injection-only service). |